SS
SS Innovations International, Inc.
SSII · NASDAQ
$3.30 -1.20% (-$0.04)
1M -12.23%
Market Cap $660.4M
P/E Ratio -
Div. Yield -
ROE 26.77%
Bulios Fair Price
$4.87
47.6% upside
Current Price
$3.3
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SSII is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 12.61x
P/B 12.37x
P/E N/A
Growth
100 /100
Growing Rev. growth 207.70%
EPS growth N/A
Book val. growth N/A
Profitability
19 /100
Weak Gross margin 47.01%
FCF margin 34.78%
Net margin 23.73%
Quality
7 /100
Poor ROIC 19.67%
Asset turnover 0.54x
ROE 26.77%
Debt
69 /100
Low Debt/Equity 0.06x
Int. coverage -6.56x
Current ratio 2.24x
Stability
46 /100
Moderate Beta 0.67x
Profitable years 0
Rev. volatility 102.34%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SSII
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Sudhir Prem Srivastava
Employees
483
Headquarters
Fort Lauderdale
Upcoming events
27 OCT
Earnings
Upcoming earnings report